Common Contracts
4 similar Executive Employment Agreement contracts by Ani Pharmaceuticals Inc
AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2025 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 (this “Amendment”) to Executive Employment Agreement, dated as of January 18, 2021 (the “Prior Agreement”), is made and entered into as of October 27, 2025 (the “Effective Date”), by and between ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Ori Gutwerg. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Prior Agreement.
AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2025 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 (this “Amendment”) to Executive Employment Agreement, dated as of July 24, 2020 (the “Prior Agreement”), is made and entered into as of October 27, 2025 (the “Effective Date”), by and between ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Nikhil Lalwani. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Prior Agreement.
AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2025 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 (this “Amendment”) to Executive Employment Agreement, dated as of January 17, 2020 (the “Prior Agreement”), is made and entered into as of October 27, 2025 (the “Effective Date”), by and between ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Stephen P. Carey. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Prior Agreement.
AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2025 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 (this “Amendment”) to Executive Employment Agreement, dated as of February 10, 2021 (the “Prior Agreement”), is made and entered into as of October 27, 2025 (the “Effective Date”), by and between ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Christopher Mutz. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Prior Agreement.